Awareness and perceptions of Long COVID among people in the REACT programme: Early insights from a pilot interview study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 04 07 2022
accepted: 11 01 2023
entrez: 26 1 2023
pubmed: 27 1 2023
medline: 31 1 2023
Statut: epublish

Résumé

Long COVID is a patient-made term describing new or persistent symptoms experienced following SARS-CoV-2 infection. The Real-time Assessment of Community Transmission-Long COVID (REACT-LC) study aims to understand variation in experiences following infection, and to identify biological, social, and environmental factors associated with Long COVID. We undertook a pilot interview study to inform the design, recruitment approach, and topic guide for the REACT-LC qualitative study. We sought to gain initial insights into the experience and attribution of new or persistent symptoms and the awareness or perceived applicability of the term Long COVID. People were invited to REACT-LC assessment centres if they had taken part in REACT, a random community-based prevalence study, and had a documented history of SARS-CoV-2 infection. We invited people from REACT-LC assessment centres who had reported experiencing persistent symptoms for more than 12 weeks to take part in an interview. We conducted face to face and online semi-structured interviews which were transcribed and analysed using Thematic Analysis. We interviewed 13 participants (6 female, 7 male, median age 31). Participants reported a wide variation in both new and persistent symptoms which were often fluctuating or unpredictable in nature. Some participants were confident about the link between their persistent symptoms and COVID-19; however, others were unclear about the underlying cause of symptoms or felt that the impact of public health measures (such as lockdowns) played a role. We found differences in awareness and perceived applicability of the term Long COVID. This pilot has informed the design, recruitment approach and topic guide for our qualitative study. It offers preliminary insights into the varied experiences of people living with persistent symptoms including differences in symptom attribution and perceived applicability of the term Long COVID. This variation shows the value of recruiting from a nationally representative sample of participants who are experiencing persistent symptoms.

Sections du résumé

BACKGROUND
Long COVID is a patient-made term describing new or persistent symptoms experienced following SARS-CoV-2 infection. The Real-time Assessment of Community Transmission-Long COVID (REACT-LC) study aims to understand variation in experiences following infection, and to identify biological, social, and environmental factors associated with Long COVID. We undertook a pilot interview study to inform the design, recruitment approach, and topic guide for the REACT-LC qualitative study. We sought to gain initial insights into the experience and attribution of new or persistent symptoms and the awareness or perceived applicability of the term Long COVID.
METHODS
People were invited to REACT-LC assessment centres if they had taken part in REACT, a random community-based prevalence study, and had a documented history of SARS-CoV-2 infection. We invited people from REACT-LC assessment centres who had reported experiencing persistent symptoms for more than 12 weeks to take part in an interview. We conducted face to face and online semi-structured interviews which were transcribed and analysed using Thematic Analysis.
RESULTS
We interviewed 13 participants (6 female, 7 male, median age 31). Participants reported a wide variation in both new and persistent symptoms which were often fluctuating or unpredictable in nature. Some participants were confident about the link between their persistent symptoms and COVID-19; however, others were unclear about the underlying cause of symptoms or felt that the impact of public health measures (such as lockdowns) played a role. We found differences in awareness and perceived applicability of the term Long COVID.
CONCLUSION
This pilot has informed the design, recruitment approach and topic guide for our qualitative study. It offers preliminary insights into the varied experiences of people living with persistent symptoms including differences in symptom attribution and perceived applicability of the term Long COVID. This variation shows the value of recruiting from a nationally representative sample of participants who are experiencing persistent symptoms.

Identifiants

pubmed: 36701357
doi: 10.1371/journal.pone.0280943
pii: PONE-D-22-18885
pmc: PMC9879384
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0280943

Subventions

Organisme : Medical Research Council
ID : MC_PC_20049
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S019669/1
Pays : United Kingdom
Organisme : Department of Health
ID : COV-LT-0040
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L01341X/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RE/18/4/34215
Pays : United Kingdom

Informations de copyright

Copyright: © 2023 Cooper et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

EClinicalMedicine. 2021 Aug;38:101019
pubmed: 34308300
Wellcome Open Res. 2020 Aug 25;5:200
pubmed: 33997297
BMC Public Health. 2014 Nov 27;14:1230
pubmed: 25428230
BJGP Open. 2020 Dec 15;4(5):
pubmed: 33051223
Med Health Care Philos. 2014 Nov;17(4):529-40
pubmed: 24740808
Lancet Respir Med. 2022 Jul;10(7):632-634
pubmed: 35525253
J Health Soc Behav. 2010;51 Suppl:S67-79
pubmed: 20943584
Glob Health Promot. 2011 Jun;18(2):18-26
pubmed: 21596936
Science. 2021 Jul 30;373(6554):491-493
pubmed: 34326224
Soc Sci Med. 2022 Jan;292:114619
pubmed: 34906823
Soc Sci Med. 2021 Jan;268:113426
pubmed: 33199035
Sociol Health Illn. 2022 Dec;44 Suppl 1:57-72
pubmed: 35023187
Lancet Infect Dis. 2021 May;21(5):601-602
pubmed: 33548193
BMJ. 2020 Sep 15;370:m3565
pubmed: 32933949
BMC Health Serv Res. 2020 Dec 20;20(1):1144
pubmed: 33342437

Auteurs

Emily Cooper (E)

Patient Experience Research Centre, School of Public Health, Imperial College London, London, United Kingdom.

Adam Lound (A)

Patient Experience Research Centre, School of Public Health, Imperial College London, London, United Kingdom.

Christina J Atchison (CJ)

Patient Experience Research Centre, School of Public Health, Imperial College London, London, United Kingdom.

Matthew Whitaker (M)

School of Public Health, Imperial College London, London, United Kingdom.
MRC Centre for Environment and Health, Imperial College London, London, United Kingdom.

Caroline Eccles (C)

REACT-Long Covid Public Advisory Group, Patient Experience Research Centre, School of Public Health, Imperial College London, London, United Kingdom.

Graham S Cooke (GS)

Department of Infectious Disease, Imperial College London, London, United Kingdom.
Imperial College Healthcare NHS Trust, London, United Kingdom.
National Institute for Health Research Imperial Biomedical Research Centre, London, United Kingdom.

Paul Elliott (P)

School of Public Health, Imperial College London, London, United Kingdom.
MRC Centre for Environment and Health, Imperial College London, London, United Kingdom.
Imperial College Healthcare NHS Trust, London, United Kingdom.
National Institute for Health Research Imperial Biomedical Research Centre, London, United Kingdom.

Helen Ward (H)

Patient Experience Research Centre, School of Public Health, Imperial College London, London, United Kingdom.
Imperial College Healthcare NHS Trust, London, United Kingdom.
National Institute for Health Research Imperial Biomedical Research Centre, London, United Kingdom.
MRC Centre for Global Infectious Disease Analysis and Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH